Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications

Available treatments for hepatitis B can control the virus but are rarely curative. This led to a global initiative to design new curative therapies for the 257 million patients affected. Discovery and development of these new therapies is contingent upon functional in vitro and in vivo hepatitis B...

Full description

Bibliographic Details
Main Authors: Jochen M. Wettengel, Bianca Linden, Knud Esser, Michael Laue, Benjamin J. Burwitz, Ulrike Protzer
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/8/1503